Copyright
©The Author(s) 2025.
World J Cardiol. Apr 26, 2025; 17(4): 104168
Published online Apr 26, 2025. doi: 10.4330/wjc.v17.i4.104168
Published online Apr 26, 2025. doi: 10.4330/wjc.v17.i4.104168
Table 2 Summary of outcomes for transcatheter aortic valve replacement vs surgical aortic valve replacement
Outcome | Follow up period | Events/totals | Risk ratio (95%CI) | P value | |
TAVR | SAVR | ||||
All-cause mortality | 1 year | 295/3834 | 370/3613 | 0.74 (0.61-0.91) | 0.004 |
2 years | 637/3421 | 631/3285 | 0.99 (0.89-1.10) | 0.87 | |
3 years | 170/1121 | 185/1043 | 0.85 (0.72-1.02) | 0.08 | |
5 years | 1124/2377 | 951/2297 | 1.13 (1.01-1.26) | 0.03 | |
Stroke | 1 year | 253/4845 | 274/4634 | 0.89 (0.67-1.19) | 0.44 |
2 years | 259/3566 | 266/3420 | 0.93 (0.75-1.16) | 0.54 | |
3 years | 98/1121 | 101/1043 | 0.90 (0.75-1.16) | 0.67 | |
5 years | 109/1380 | 115/1299 | 0.89 (0.69-1.14) | 0.43 | |
Disabling stroke | 1 year | 127/3814 | 157/3688 | 0.77 (0.53-1.13) | 0.05 |
2 years | 91/2692 | 115/2575 | 0.72 (0.48-1.08) | 0.11 | |
5 years | 98/1507 | 86/1475 | 1.11 (0.84-1.47) | 0.45 | |
Cardiac mortality | 1 year | 225/3914 | 248/3804 | 0.87 (0.70-1.10) | 0.24 |
2 years | 320/3566 | 331/3420 | 0.94 (0.81-1.08) | 0.38 | |
3 years | 112/1121 | 121/1043 | 0.86 (0.68-1.09) | 0.21 | |
5 years | 448/2000 | 398/1961 | 1.13 (1.01-1.27) | 0.04 | |
Myocardial infarction | 1 year | 74/4346 | 81/4156 | 0.88 (0.64-1.21) | 0.42 |
2 years | 89/3566 | 87/3420 | 1.00 (0.75-1.35) | 0.98 | |
3 years | 33/1121 | 23/1043 | 1.33 (0.79-2.26) | 0.28 | |
5 years | 110/2000 | 99/1961 | 0.87 (0.48-1.59) | 0.04 | |
New permanent pacemaker insertion | 1 year | 483/3482 | 245/3360 | 2.03 (1.41-2.94) | 0.0002 |
2 years | 681/3566 | 274/3420 | 2.45 (1.54-3.90) | 0.0002 | |
3 years | 264/1121 | 104/1043 | |||
2.33 (1.83-2.98) | < 0.00001 | ||||
5 years | 287/2000 | 189/1961 | 1.72 (1.03-2.88) | 0.04 | |
Acute kidney injury | 1 year | 98/3027 | 165/2929 | 0.54 (0.34-0.86) | 0.009 |
2 years | 95/2614 | 470/2527 | 0.35 (0.09-1.39) | < 0.00001 | |
5 years | 24/348 | 24/351 | 1.01 (0.58-1.74) | 0.98 | |
Hospitalization | 1 year | 297/2492 | 293/2437 | 0.98 (0.76-1.27) | 0.91 |
2 years | 424/3030 | 356/2926 | 1.14 (0.95-1.37) | 0.15 | |
5 years | 454/1855 | 364/1825 | 1.16 (0.87-1.55) | 0.31 | |
Aortic valve re-intervention | 1 year | 53/3856 | 17/3694 | 2.68 (1.54-4.64) | 0.0005 |
2 years | 53/3073 | 18/2934 | 2.58 (1.40-4.73) | 0.002 | |
3 years | 16/1121 | 7/1043 | 2.50 (0.33-18.84) | 0.37 | |
5 years | 36/1652 | 19/1610 | 1.89 (0.66-5.36) | 0.23 | |
New atrial fibrillation | 1 year | 299/3444 | 686/3298 | 0.53 (0.31-0.89) | 0.02 |
2 years | 332/2488 | 846/2385 | 0.39 (0.30-0.49) | < 0.00001 | |
5 years | 196/1507 | 446/1475 | 0.40 (0.27-0.60) | < 0.00001 | |
Paravalvular leak | 2 years | 23/1431 | 6/1397 | 3.62 (1.46-8.95) | 0.005 |
Major bleeding | 1 year | 406/3485 | 945/3384 | 0.43 (0.30-0.62) | < 0.00001 |
2 years | 330/2410 | 385/2264 | 0.74 (0.52-1.04) | 0.08 | |
Major vascular complication | 1 year | 296/3485 | 107/3384 | 3.07 (1.75-5.40) | < 0.0001 |
2 years | 232/3344 | 107/3211 | 2.39 (1.39-4.11) | 0.002 |
- Citation: Moradi I, Mustafa MS, Sardar Sheikh J, Shojai Rahnama B, Fredericks M, Kumar Yennam A, Arain M, Saha U, Richard Ma A, Nagendran A, Bin Omer M, Armaghan M, Jaimes DCC, Avinash Bojanki NLSV, Shafique MA. Comparative effectiveness of transcatheter vs surgical aortic valve replacement: A systematic review and meta-analysis. World J Cardiol 2025; 17(4): 104168
- URL: https://www.wjgnet.com/1949-8462/full/v17/i4/104168.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i4.104168